ArticleBreast cancer research and treatment2026

Antacid co-treatment and pregnane X receptor genetic polymorphisms are survival determinants in patients treated with palbociclib.

Fanny Leenhardt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.